MiMedx Group Inc (MDXG) Receives Price Target

MiMedx Group Inc (MDXG) : The highest short term price target forecast on MiMedx Group Inc (MDXG) is $13 and the lowest target price is $9. A total of 5 equity analysts are currently covering the company. The average price of all the analysts is $11.6 with a standard deviation of $1.52.

MiMedx Group Inc (MDXG) : Zacks Investment Research ranks MiMedx Group Inc (MDXG) as 3, which is a Hold recommendation. 4 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. A total of 1 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 5 research analysts is 1.4, which indicates as a Strong Buy.


MiMedx Group Inc (NASDAQ:MDXG): The stock opened at $7.25 on Thursday but the bulls could not build on the opening and the stock topped out at $7.27 for the day. The stock traded down to $7.02 during the day, due to lack of any buying support eventually closed down at $7.14 with a loss of -1.38% for the day. The stock had closed at $7.24 on the previous day. The total traded volume was 726,239 shares.

MiMedx Group, Inc. (MiMedx) is an integrated developer, manufacturer and marketer of regenerative biomaterial products and bioimplants processed from human amniotic membrane. The Companys biomaterial platform technologies include AmnioFix and EpiFix, its tissue technologies processed from human amniotic membrane that is derived from donated placentas. Through its donor program, mothers delivering full-term Cesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. MiMedx processes the human amniotic membrane utilizing its Purion Process to produce an implant, which is referred as an allograft. MiMedx is the supplier of amniotic tissue, having supplied over 350,000 allografts for application in the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental sectors of healthcare. Its CollaFix technology combines a means of creating fibers from soluble collagen and a cross-linking process.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.